According to the manufacturer Sandoz d.d., an insufficient amount of the Amoxiclav medication (Amoxicillin/clavulanic acid) in the pharmaceutical market is due to the fact that the amount of imported medications have decreased (due to logistics disturbances), and demand exceeds supply.